Correlation Between MedMira and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both MedMira and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedMira and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MedMira and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on MedMira and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedMira with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedMira and PsyBio Therapeutics.
Diversification Opportunities for MedMira and PsyBio Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between MedMira and PsyBio is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding MedMira and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and MedMira is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedMira are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of MedMira i.e., MedMira and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between MedMira and PsyBio Therapeutics
If you would invest 0.01 in PsyBio Therapeutics Corp on October 5, 2024 and sell it today you would earn a total of 0.00 from holding PsyBio Therapeutics Corp or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
MedMira vs. PsyBio Therapeutics Corp
Performance |
Timeline |
MedMira |
PsyBio Therapeutics Corp |
MedMira and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MedMira and PsyBio Therapeutics
The main advantage of trading using opposite MedMira and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedMira position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.MedMira vs. Oxford Cannabinoid Technologies | MedMira vs. Pharming Group NV | MedMira vs. Kane Biotech | MedMira vs. Health Sciences Gr |
PsyBio Therapeutics vs. Health Sciences Gr | PsyBio Therapeutics vs. Vg Life Sciences | PsyBio Therapeutics vs. MedMira | PsyBio Therapeutics vs. Oxford Cannabinoid Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |